Metabolic Tumor Volume Response Assessment Using (11)C-Methionine Positron Emission Tomography Identifies Glioblastoma Tumor Subregions That Predict Progression Better Than Baseline or Anatomic Magnetic Resonance Imaging Alone

PURPOSE: To evaluate whether response assessment of newly diagnosed glioblastoma at 3 months using (11)C-methionine-positron emission tomography (MET-PET) is better associated with patient outcome compared with baseline MET-PET or anatomic magnetic resonance imaging alone. METHODS AND MATERIALS: Pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Sean, Li, Pin, Schipper, Matthew, Junck, Larry, Piert, Morand, Lawrence, Theodore S., Tsien, Christina, Cao, Yue, Kim, Michelle M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Central Nervous System Tumor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004943/
https://www.ncbi.nlm.nih.gov/pubmed/32051890
http://dx.doi.org/10.1016/j.adro.2019.08.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004943/
https://www.ncbi.nlm.nih.gov/pubmed/32051890
http://dx.doi.org/10.1016/j.adro.2019.08.004

Ejemplares similares